Research Groups and R&D Platforms: Diagnostics, Personalized medicine

Research Group:
Computational Biomedicine and Bioinformatics

Laura Elo
laura.elo[at]utu.fi

Turku Bioscience,
University of Turku

Laura Elo

Computational Biomedicine

Autoimmune diseases, Bioinformatics, Biomarker, Biomedicine, Cancer, Cardiovascular diseases, Data mining, Diabetes, Diagnostics, Epigenomics, Genomics, Imaging, Machine learning, Metabolic diseases, Molecular diagnostics, Next-generation sequencing, Pattern recognition, Personalized medicine, Proteomics, Systems Biology, Target discovery

Research Group:
BioNanoMaterials research group

Jessica Rosenholm
Jessica.rosenholm[at]abo.fi

Pharmaceutical Sciences Laboratory,
Åbo Akademi University

Jessica Rosenholm

Pharmaceutical Sciences Laboratory

 

Antibacterial, Biomedicine, Biopharmaceuticals, Biotechnology, Cancer, Diagnostics, Drug delivery, Drug solubility, Drug stability, Electron microscopy, Fluorescence spectroscopy, Formulation, FTIR or RAMAN spectroscopy, Imaging software, Infection, Lead optimization, Musculoskeletal disorders, Nanoparticles, Natural products, Organic compounds, Particle morphology, Particle size analysis, Personalized medicine, Pharmacy, Physico-chemical properties, Porosity, Powder flow characterization, Powder X-ray diffraction, Preclinical development, Screening, Skin diseases, Super-resolution imaging, Surface area, Synthetic chemistry, Thermal analysis, Zeta potential

Research Group:
Drug Discovery and Diagnostics tools and detection methods

Harri Härmä
harri.harma[at]utu.fi

Analytical Chemistry,
University of Turku

Harri Härmä

Antibodies, Assay development, Biomarker, Biomedicine, Biomolecular chemistry, Biotechnology, Clinical Chemistry, Diagnostics, Drug target, Fluorescence spectroscopy, FTIR or RAMAN microscopy, FTIR or RAMAN spectroscopy, In Vitro Diagnostics, Molecular diagnostics, Nanoparticles, Next-generation sequencing, Nucleic acids, Particle size analysis, Pattern recognition, Personalized medicine, Receptor, Screening, Signaling, Thermal analysis

Research Group:
New tools to target harmful inflammations and cancer

Sirpa Jalkanen
sirjal[at]utu.fi

Department of Medical Microbiology and Immunology,
University of Turku

Sirpa Jalkanen

The Research Group

Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biopharmaceuticals, Breast cancer, Cancer, Cardiovascular diseases, Clinical Medicine, Colorectal cancer, Diagnostics, Disease models, Drug target, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Lung cancer, Melanoma, Metabolic diseases, Molecular Cell Biology, Molecular diagnostics, Musculoskeletal disorders, Neurological disorders, Obesity, Ovarian cancer, Pathology, Personalized medicine, PET, Prostate cancer, Receptor, Signaling, Skin diseases, Squamous cell carcinoma, Target discovery

Research Group:
Prognostic features in triple-negative breast carcinoma

Pauliina Kronqvist
paukro[at]utu.fi

Institute of Biomedicine,
University of Turku

Pauliina Kronqvist

Cell cycle regulator secrin as a prognosticator in breast cancer

Biomarker, Breast cancer, Cancer, Data mining, Diagnostics, Genomics, Imaging, Molecular diagnostics, Next-generation sequencing, Pathology, Personalized medicine, Point of care

Research Group:
Biomedical Epigenomics

Riikka Lund
riikka.lund[at]utu.fi

Biomedical Epigenomics Group,
Turku Bioscience,

University of Turku

Riikka Lund

Biomedical Epigenomics

Ageing-related diseases, Basic research, Biomarker, Biomedicine, Biotechnology, Data mining, Diagnostics, Disease models, Drug target, Epigenomics, Genetics, Genomics, Imaging, Molecular Biology, Molecular Cell Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Target discovery